Literature DB >> 8358990

A case of Sjögren's syndrome complicating immune-mediated aplastic anaemia.

M Satoh1, H Yamagata, F Watanabe, Y Matsushita, S Nakayama, M Murakami, J Matsuyama, S Oshima, M Akizuki.   

Abstract

A 78-year-old Japanese woman with Sjögren's syndrome complicating immune-mediated aplastic anaemia is described. A diagnosis of aplastic anaemia was made from severe pancytopenia with hypoplastic marrow. Laboratory studies suggested an association of bone marrow suppressive T-lymphocytes with the pathogenesis of aplastic anaemia. Following the administration of mepithiostan and prednisolone, pancytopenia improved gradually. Two years after the onset of aplastic anaemia, Raynaud's phenomenon developed and examinations revealed the existence of keratoconjunctivitis sicca and anti-SSA/Ro and anti-SSB/La antibodies.

Entities:  

Mesh:

Year:  1993        PMID: 8358990     DOI: 10.1007/bf02231538

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  Serum inhibitors of hematopoiesis in a patient with aplastic anemia and systemic lupus erythematosus. Recovery after exchange plasmapheresis.

Authors:  J J Fitchen; M J Cline; A Saxon; D W Golde
Journal:  Am J Med       Date:  1979-03       Impact factor: 4.965

2.  Successful treatment of aplastic anemia associated with chronic thyroiditis and Sjögren's syndrome.

Authors:  H Yoshida; M Wakashin; K Okuda
Journal:  J Rheumatol       Date:  1986-12       Impact factor: 4.666

3.  Hematologic aspects of systemic lupus erythematosus. Current concepts.

Authors:  D R Budman; A D Steinberg
Journal:  Ann Intern Med       Date:  1977-02       Impact factor: 25.391

4.  Heterogeneity of pathogenetic mechanisms in aplastic anemia. Efficacy of therapy based on in-vitro results.

Authors:  N I Abdou; J D Verdirame; M Amare; N L Abdou
Journal:  Ann Intern Med       Date:  1981-07       Impact factor: 25.391

Review 5.  Primary Sjogren syndrome: clinical and immunopathologic features.

Authors:  R I Fox; F V Howell; R C Bone; P Michelson
Journal:  Semin Arthritis Rheum       Date:  1984-11       Impact factor: 5.532

Review 6.  Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis.

Authors:  B M Camitta; R Storb; E D Thomas
Journal:  N Engl J Med       Date:  1982-03-18       Impact factor: 91.245

7.  Aplastic anemia and lymphoma in Sjögren's syndrome.

Authors:  K H Fye; T E Daniels; J Zulman; J P Michalski; R Jaffe; N Talal
Journal:  Arthritis Rheum       Date:  1980-11

8.  Aplastic anemia complicating systemic lupus erythematosus: response to androgens in two patients.

Authors:  R B Stricker; M A Shuman
Journal:  Am J Hematol       Date:  1984-08       Impact factor: 10.047

9.  Serum inhibitor in systemic lupus erythematosus associated with aplastic anemia.

Authors:  B J Brooks; H E Broxmeyer; C F Bryan; S H Leech
Journal:  Arch Intern Med       Date:  1984-07

10.  Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide.

Authors:  M J Walport; W N Hubbard; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-18
View more
  1 in total

Review 1.  Ocular manifestations of idiopathic aplastic anemia: retrospective study and literature review.

Authors:  Ahmad M Mansour; Jong Wook Lee; Seung Ah Yahng; Kyu Seop Kim; Maha Shahin; Nelson Hamerschlak; Rubens N Belfort; Shree K Kurup
Journal:  Clin Ophthalmol       Date:  2014-04-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.